Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.63% |
| 2 | Financials | 9.78% |
| 3 | Healthcare | 7.32% |
| 4 | Industrials | 7.25% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Howmet Aerospace
HWM
$105B
| $1.64B | 0.09% |
6,100,788
+169,263
| +3% | +$43.5M |
|
202
Energy Transfer Partners
ET
$72.8B
| $1.64B | 0.09% |
85,614,431
-1,615,983
| -2% | -$31.3M |
|
203
Freeport-McMoran
FCX
$114B
| $1.63B | 0.09% |
25,994,123
-233,529
| -0.9% | -$15M |
|
204
Altria Group
MO
$114B
| $1.63B | 0.09% |
22,702,935
-1,752,794
| -7% | -$122M |
|
205
Intercontinental Exchange
ICE
$91.1B
| $1.61B | 0.09% |
13,117,904
-1,369,809
| -9% | -$206M |
|
206
Vertex Pharmaceuticals
VRTX
$140B
| $1.61B | 0.09% |
3,242,139
+53,258
| +2% | +$23.6M |
|
207
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.3B
| $1.6B | 0.08% |
26,020,258
+2,428,587
| +10% | +$144M |
|
208
ICICI Bank
IBN
$108B
| $1.58B | 0.08% |
54,395,929
+6,278,191
| +13% | +$170M |
|
209
Nu Holdings
NU
$71.6B
| $1.58B | 0.08% |
117,966,561
-23,661,822
| -17% | -$319M |
|
210
General Dynamics
GD
$102B
| $1.57B | 0.08% |
4,440,256
-735,507
| -14% | -$252M |
|
211
American Tower
AMT
$82.9B
| $1.57B | 0.08% |
9,610,971
+27,048
| +0.3% | +$4.87M |
|
212
Invesco NASDAQ 100 ETF
QQQM
$103B
| $1.56B | 0.08% |
5,160,404
+1,026,050
| +25% | +$291M |
|
213
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $1.55B | 0.08% |
19,441,067
-6,806,981
| -26% | -$545M |
|
214
State Street Energy Select Sector SPDR ETF
XLE
$41.1B
| $1.55B | 0.08% |
29,181,455
-3,435,892
| -11% | -$196M |
|
215
Capital Group Growth ETF
CGGR
$25.2B
| $1.53B | 0.08% |
32,389,025
+2,646,518
| +9% | +$120M |
|
216
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $1.53B | 0.08% |
20,167,455
+800,081
| +4% | +$59M |
|
217
Medtronic
MDT
$118B
| $1.52B | 0.08% |
19,444,871
-1,272,158
| -6% | -$103M |
|
218
Accenture
ACN
$114B
| $1.51B | 0.08% |
12,169,874
+748,345
| +7% | +$130M |
|
219
Roivant Sciences
ROIV
$26.3B
| $1.51B | 0.08% |
42,592,905
-9,235,420
| -18% | -$273M |
|
220
Marathon Petroleum
MPC
$101B
| $1.51B | 0.08% |
5,887,382
-186,161
| -3% | -$45.7M |
|
221
Rockwell Automation
ROK
$47.9B
| $1.51B | 0.08% |
3,040,314
+216,767
| +8% | +$94.3M |
|
|
QXO
222
QXO Inc
QXO
$14.3B
| $1.49B | 0.08% |
86,495,549
+11,860,833
| +16% | +$221M |
|
223
Vanguard FTSE Europe ETF
VGK
$31.3B
| $1.49B | 0.08% |
16,832,886
-568,543
| -3% | -$49.8M |
|
224
AstraZeneca
AZN
$263B
| $1.49B | 0.08% |
7,859,306
+889,992
| +13% | +$167M |
|
225
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.84B
| $1.48B | 0.08% |
19,710,947
+3,382,036
| +21% | +$254M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.